If you’re attending ARVO, you can see OHRP’s poster on Squalamine eye drops: http://finance.yahoo.com/news/ohr-pharmaceutical-present-arvo-annual-123000769.html Abstract title: “A Novel Eye Drop Formulation of Squalamine For Exudative AMD: Evaluation Of Ocular Distribution And Ocular Safety In Rabbits” Recap: Ten years after this drug was first tested in human eyes, we have a distribution and safety study in rabbits! I’m willing to bet that this program won’t work for the reason mentioned in #msg-75138549.